Bluebird Stock Performance

BLUE
 Stock
  

USD 7.59  0.07  0.93%   

On a scale of 0 to 100, Bluebird Bio holds a performance score of 7. The firm shows a Beta (market volatility) of 1.9716, which signifies a somewhat significant risk relative to the market. Let's try to break down what Bluebird's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bluebird Bio will likely underperform. Although it is vital to follow Bluebird Bio historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-seven technical indicators for Bluebird Bio, which you can use to evaluate the performance of the firm. Please makes use of Bluebird Bio semi variance, and the relationship between the maximum drawdown and accumulation distribution to make a quick decision on whether Bluebird Bio price patterns will revert.
  
Bluebird Performance
7 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bluebird Bio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, Bluebird Bio exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
1544:1000
Last Split Date
2021-11-05

Bluebird Price Channel

Quick Ratio0.95
Fifty Two Week Low2.87
Target High Price10.00
Fifty Two Week High11.70
Target Low Price3.00

Bluebird Bio Relative Risk vs. Return Landscape

If you would invest  590.00  in Bluebird Bio on August 28, 2022 and sell it today you would earn a total of  169.00  from holding Bluebird Bio or generate 28.64% return on investment over 90 days. Bluebird Bio is currently generating 0.5959% in daily expected returns and assumes 6.4107% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than Bluebird, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Bluebird Bio is expected to generate 4.67 times more return on investment than the market. However, the company is 4.67 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The DOW is currently generating roughly 0.08 per unit of risk.

Bluebird Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bluebird Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bluebird Bio, and traders can use it to determine the average amount a Bluebird Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.093

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsBLUE
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 6.41
  actual daily
 
 55 %
of total potential
 
5555
Expected Return
 0.6
  actual daily
 
 11 %
of total potential
 
1111
Risk-Adjusted Return
 0.09
  actual daily
 
 7 %
of total potential
 
77
Based on monthly moving average Bluebird Bio is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bluebird Bio by adding it to a well-diversified portfolio.

About Bluebird Bio Performance

To evaluate Bluebird Bio Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bluebird Bio generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bluebird Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bluebird Bio market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Bluebird's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(68.34) (73.74) 
Return on Average Assets(69.00) (74.45) 
Return on Average Equity(94.76) (97.25) 
Return on Invested Capital(0.97) (0.99) 
Return on Sales(201.53) (206.83) 

Things to note about Bluebird Bio

Checking the ongoing alerts about Bluebird Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bluebird Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Bluebird Bio Alerts

Equity Alerts and Improvement Suggestions

Bluebird Bio is way too risky over 90 days horizon
Bluebird Bio appears to be risky and price may revert if volatility continues
Bluebird Bio has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 6.09 M. Net Loss for the year was (507.45 M) with loss before overhead, payroll, taxes, and interest of (351.14 M).
Bluebird Bio currently holds about 132.51 M in cash with (506.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Bluebird Bio has a frail financial position based on the latest SEC disclosures
Over 82.0% of the company shares are held by institutions such as insurance companies
Continue to Trending Equities. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Bluebird Bio price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
623.5 M
Quarterly Revenue Growth YOY
(0.93) 
Return On Assets
(0.29) 
Return On Equity
(0.84) 
The market value of Bluebird Bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Bluebird Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.